World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
114
Citations
78374
World Ranking
4621
National Ranking
2509

Research.com Recognitions

  • 1990 - Fellow of Alfred P. Sloan Foundation
  • 1986 - Fellow of the American Statistical Association (ASA)

Overview

Donald A. Berry is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medicine and biochemistry, genetics, and molecular biology, with a particular emphasis on oncology and cancer research.

Their published work spans several subfields including oncology, cancer research, statistics and probability, radiology, nuclear medicine and imaging, as well as pulmonary and respiratory medicine. The main topics addressed in their research include breast cancer treatment studies, cancer genomics and diagnostics, statistical methods in clinical trials, cancer treatment and pharmacology, HER2/EGFR in cancer research, radiomics and machine learning in medical imaging, and advanced breast cancer therapies.

Some of the recent papers authored or co-authored by Donald A. Berry are:

  • "A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody" (2021, Alzheimer s Research & Therapy)
  • "Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer" (2020, JAMA Oncology)
  • "Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia" (2020, JAMA Oncology)
  • "Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery" (2021, The Lancet Oncology)
  • "Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial" (2021, Cancer Cell)

Frequent co-authors collaborating with Donald A. Berry include:

  • Laura J. Esserman
  • Christina Yau
  • Angela DeMichele
  • Douglas Yee
  • Nola M. Hylton

The scientist has published extensively in several key venues, notably:

  • Journal of Clinical Oncology
  • Cancer Research
  • UNC Libraries
  • Neuro-Oncology
  • Clinical Cancer Research

Their contributions have been recognized through awards such as:

  • Fellow of Alfred P. Sloan Foundation (1990)
  • Fellow of the American Statistical Association (ASA) (1986)

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Effect of Screening and Adjuvant Therapy on Mortality From Breast Cancer

    Donald A. Berry;Kathleen A. Cronin;Sylvia Plevritis;Dennis G. Fryback

  • Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

    Marc L. Citron;Donald A. Berry;Constance Cirrincione;Clifford Hudis

  • Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

    I. Craig Henderson;Donald A. Berry;George D. Demetri;Constance T. Cirrincione

  • Revision of the American Joint Committee on Cancer Staging System for Breast Cancer

    S. Eva Singletary;Craig Allred;Pandora Ashley;Lawrence W. Bassett

  • Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

    Aman U. Buzdar;Nuhad K. Ibrahim;Deborah Francis;Daniel J. Booser

  • Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

    Joe Y Chang;Suresh Senan;Marinus A. Paul;Reza John Mehran

  • Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review

    Peter B. Bach;Joshua N. Mirkin;Thomas K. Oliver;Christopher G. Azzoli

  • Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial

    David J. Wilber;Carlo Pappone;Petr Neuzil;Angelo De Paola

  • The decrease in breast-cancer incidence in 2003 in the United States

    Peter M. Ravdin;Kathleen A. Cronin;Nadia Howlader;Christine D. Berg

  • c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer

    Hyman B. Muss;Ann D. Thor;Donald A. Berry;Timothy Kute

  • Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343

    Kevin S. Hughes;Lauren A. Schnaper;Jennifer R. Bellon;Constance T. Cirrincione

  • Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer

    Kevin S. Hughes;Lauren A. Schnaper;Donald Berry;Constance Cirrincione

  • Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

    William M. Sikov;Donald A. Berry;Charles M. Perou;Baljit Singh

  • Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

    M C Liu;G R Oxnard;E A Klein;C Swanton

  • Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

    Donald A. Berry;Constance Cirrincione;I. Craig Henderson;Marc L. Citron

  • Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2

    Giovanni Parmigiani;Donald A. Berry;Omar Aguilar

  • Meta-analyses of Colorectal Cancer Risk Factors

    Constance M. Johnson;Caimiao Wei;Joe E. Ensor;Derek J. Smolenski

  • HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

    Daniel F. Hayes;Ann D. Thor;Lynn G. Dressler;Donald Weaver

  • Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer

    Daniel R. Budman;Donald A. Berry;Constance T. Cirrincione;I. Craig Henderson

Frequent Co-Authors

Laura J. Esserman
Laura J. Esserman University of California, San Francisco
Christina Yau
Christina Yau University of California, San Francisco
Eric P. Winer
Eric P. Winer Yale University
Angela DeMichele
Angela DeMichele University of Pennsylvania
Laura J. van't Veer
Laura J. van't Veer University of California, San Francisco
Clifford A. Hudis
Clifford A. Hudis Memorial Sloan Kettering Cancer Center
Hope S. Rugo
Hope S. Rugo University of California, San Francisco
Kathy S. Albain
Kathy S. Albain Loyola University Chicago
Douglas Yee
Douglas Yee University of Minnesota
Judy C. Boughey
Judy C. Boughey Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering a career in Medicine or related fields in the USA, a variety of online degree options can help jumpstart your journey—or advance your expertise. These pathways offer flexibility, affordability, and specialization, making them popular choices for students and working professionals alike.

Aspiring practical nurses looking for convenient study formats may consider an lpn program, which allows you to start working in healthcare quickly due to its focused and accelerated curriculum. If your interest is in leadership, management, or healthcare business operations, consider the cheapest online healthcare administration degree to gain essential organizational skills while controlling costs.

Nurses aiming for higher qualifications often pursue a Doctor of Nursing Practice through dnp programs without dissertation, ideal for those who want to focus on clinical practice rather than heavy research. Additionally, mental health is an essential field in medicine today, and the psych np programs provide an accelerated route to specialize in psychiatric and mental health care. Together, these pathways widen opportunities in healthcare beyond the traditional MD route.

Best Scientists Citing Donald A. Berry

Trending Scientists